
Ernamín at the 55th Congress of the Spanish Society of Nephrology
From October 16–18, the 55th edition of the Congress of the Spanish Society of Nephrology (SEN) took place in Oviedo For the first time, and following the launch of Ernamín, ERN Laboratories participated as a collaborator in the event, with a stand in the commercial exhibition area and by organizing a technical forum featuring high-level speakers The...
Incremental Drug Innovation: A Priority Focus for Laboratorios ERN
David Solanes López, General Manager of Laboratorios ERN, was appointed Academician of the Royal Academy of Pharmacy of Catalonia on October 6, 2025, in the industrial section Solanes dedicated his induction speech to incremental innovation, an area closely linked to his professional career and to Laboratorios ERN’s commitment to developing solutions...
FDA has approved intravenous fosfomycin for the treatment of cUTI
On October 22, 2025, the US Food and Drug Administration (FDA) approved intravenous fosfomycin for the treatment of complicated urinary tract infections (cUTI) Laboratorios ERN expresses its satisfaction with the recent approval by the US Food and Drug Administration (FDA) of intravenous fosfomycin for the treatment of patients aged 18 years and older...
Laboratorios ERN collaborates with the Master’s in Logistics and Supply Chain Management at the University of Barcelona
The collaboration with the Institut de Formació Contínua–IL3 allows students to apply their knowledge to a real case in the pharmaceutical sector Laboratorios ERN has strengthened its ties with the academic field through a collaboration with the Master’s in Logistics and Supply Chain Management at the Institut de Formació Contínua–IL3, part of...
“Una rosa per no oblidar”
Once again, on the occasion of Sant Jordi's Day, April 23rd, 2025, Laboratorios ERN has renewed its commitment to solidarity by joining the Fundació Alzheimer Catalunya As we did in 2024, we wanted to convey a message of support to all people affected by Alzheimer's disease Each rose delivered represents much more than a flower: it is a living symbol of...
Laboratorios ERN’s Presence at the Meeting with the President of the Spanish Government
David Solanes López, General Director of Laboratorios ERN, met on February 12, 2025, with the President of the Government of Spain, Pedro Sánchez, along with other executives from the national and multinational pharmaceutical industry, Farmaindustria, EFPIA, and the Minister of Health, Mónica García, the Minister of Industry, Jordi Hereu, and other...
Biocat reaffirms its leadership in innovation with the first Board of Trustees meeting under Salvador Illa’s Presidency
Barcelona, December 17, 2024 Biocat, the strategic driver of the life sciences and healthcare sector in Catalonia, held a historic Board of Trustees meeting on December 17 at the Palau de la Generalitat This meeting marked a milestone, being the first under the new Catalan Government administration and with Salvador Illa, President of the Government of...
ERN applies for the MOVES III grant
LABORATORIOS ERN has applied for the MOVES III program grant for the installation of electric vehicle charging points at its Barcelona headquarters and its center in Sant Andreu de la Barca The charging points, already operational, reflect its commitment to sustainability and the promotion of electric mobility as a key pillar of its environmental...
Keep Your Company Awake
Last Monday, October 28th, the session “Keep Your Company Awake” was held at the offices of Laboratorios ERN It was led by Dr Antoni Esteve, Chairman & Founder of AdSalutem Sleep Institute, together with Dr Marta Portero, PhD in Neuroscience and a Licensed Clinical and Health Psychologist from UAB The purpose of the session was to raise awareness...